PJWM
JAZZ icon

Philip James Wealth Mangement’s Jazz Pharmaceuticals JAZZ Stock Holding History

Philip James Wealth Mangement’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49M Sell
14,473
-986
-6% -$216K 0.39% 55
2026
Q1 		$2.92M Sell
15,459
-477
-3% -$83.4K 0.34% 57
2025
Q4 		$2.71M Sell
15,936
-96
-0.6% -$14.7K 0.31% 61
2025
Q3 		$2.11M Buy
16,032
+235
+1% +$28.2K 0.25% 67
2025
Q2 		$1.68M Buy
15,797
+4,675
+42% +$508K 0.21% 72
2025
Q1 		$1.38M Buy
11,122
+463
+4% +$60.4K 0.17% 74
2024
Q4 		$1.31M Buy
10,659
+3,205
+43% +$378K 0.17% 75
2024
Q3 		$830K Buy
+7,454
New +$817K 0.1% 81

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Philip James Wealth Mangement's JAZZ Position: Q2 2026 in Review

Philip James Wealth Mangement reduced its Jazz Pharmaceuticals (JAZZ) stake by 6.4% in Q2 2026, selling an estimated $216K and leaving 14,473 shares worth $3.49M. The position accounts for 0.39% of the portfolio, ranked #55.

Philip James Wealth Mangement first reported a position in JAZZ in Q3 2024 and has held it in 8 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Philip James Wealth Mangement held 14,473 shares of Jazz Pharmaceuticals worth $3.49M as of Q2 2026.
  • Philip James Wealth Mangement sold 986 Jazz Pharmaceuticals shares in Q2 2026, an estimated $216K.
  • Jazz Pharmaceuticals made up 0.39% of Philip James Wealth Mangement's portfolio in Q2 2026, its #55 holding.
  • Philip James Wealth Mangement first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Philip James Wealth Mangement's 13F filing for Q2 2026, filed 27 Jul 2026.